Ignite Creation Date:
2024-05-05 @ 12:09 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00264667
Status:
COMPLETED
Last Update Posted:
2016-10-28
First Post:
2005-12-09
Brief Title:
Study In Patients With Dyslipidaemia
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
A RandomisedDouble-blind Parallel Group Placebo-controlled Multicentre Study to Evaluate the Safety Tolerability and Efficacy of Oral GW677954 Capsules 25mg 5mg 10mg and 20mg a Day for 24 Weeks in Overweight Dyslipidaemic Subjects
Status:
COMPLETED
Status Verified Date:
2016-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Study in patients with dyslipidaemia
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None